LIVE WEBINAR – Diagnosis of diabetes in ethnic minorities: challenges, and strategies to bridge the care gap
Saturday, 17 July 2021 from 12:00 to 13:00 CEST
from 12:00 to 13:00 CEST
from 7:00 to 8:00 ART
from 18:00 to 19:00 CST
Although diabetes and pre-diabetes are worldwide problems, the cut-off point for measures of hyperglycemia are different between races and there are differences in attitudes to care – further exaggerated by economic, cultural and social factors. Health inequality in the community is responsible for poorer outcomes for those with diabetes from certain ethnic or racial groups, those from lower income households and those who attain a low standard of education. Tackling disparities in diabetes healthcare is, therefore, a major global goal of the diabetes community, ensuring all patients, irrespective of race, ethnicity or income receive the best care. However, the health inequality caused by racial, ethnic or social differences is difficult to address, and requires sensitivity and perseverance from healthcare professionals, as well as the latest information and guidelines to support decision-making. This live webinar will describe the current gap in the care of diabetes in ethnic minorities, suggesting strategies for healthcare professionals to identify those who are not engaging with diabetes treatment or those who are currently marginalised in healthcare.
By attending this live webinar, participants will:
- Increase their awareness of healthcare disparities relating to metabolic disorders among different ethnic groups
- Understand the factors responsible for healthcare inequality
- Learn effective strategies to ensure all patients have access to support for their diabetes and pre-diabetes.
This webinar is designed for Diabetologists, Endocrinologists, General Practitioners, Internists and specialists involved in the diagnosis and management of patients with diabetes.
The official language of this live educational conference is English.
Simultaneous translation into Spanish and Mandarin Chinese will be provided.
Department of Experimental Medicine
University of Rome “La Sapienza”
Associate Professor of Endocrinology
Endocrinology and Diabetes Unit
University Campus Bio-Medico of Rome (UCBM)
Professor of Medicine, Division of Endocrinology
Director of the Diabetes and Endocrinology section
Grady Memorial Hospital
Atlanta (GA), USA
Scientific Seminars International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME®) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices and other products (other than those uses indicated in approved product labelling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter).
We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement nor a recommendation on the part of Scientific Seminars International Foundation. All presentations represent solely the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Declared receipt of grants/research supports from Astra Zeneca, of honoraria or consultation fees from Merck-Serono and Abbott and participation in Merck-Serono, Pikdare, AstraZeneca, Lilly and Abbott speaker’s bureau.
Declared receipt of grant and contracts from Abiogen, of honoraria or consultation fees from Lilly and to be member of UCB advisory board.
Guillermo E. Umpierrez
Declared receipt of research grant (to Emory University) from Novo Nordisk, Astra Zeneca and Dexcom.
Scientific Seminars International Foundation
Senior CME Manager: Flaminia Masprone
T +39 380 1504116 – F +39 06 4827169
This independent educational program is made possible thanks to an educational grant received from Merck Healthcare KGaA Darmstadt Germany.
Copyright 2021 Scientific Seminars International Foundation